NCT00786448View on ClinicalTrials.gov

Post Marketing Surveillance Study on Emselex After Launch in Germany

CompletedOBSERVATIONAL

Enrollment

5,821

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

Overactive Bladder

Interventions

DRUG

Darifenacin, Emselex (BAY79-4998)

Patients from routine practice

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY